Blue Owl Capital Holdings »

Bolt Projs Hldgs shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Bolt Projs Hldgs shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Bolt Projs Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Bolt Projs Hldgs held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Projs Hldgs by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 167k 0.00

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Bolt Projs Hldgs

Highbridge Capital Management
Cowen And Company
K2 Principal Fund
Polar Securities
Security Benefit Life Insurance
OZ Management
Blue Owl Capital Holdings
Canyon Capital Advisors
Calamos Advisors
D. E. Shaw & Co
Q Global Advisors
Maso Capital Partners
Wolverine Asset Management
Antara Capital
Citadel Advisors

View all funds holding Bolt Projs Hldgs